Cover Image
Market Research Report

Diabetes Care Devices Market - Global Opportunity Analysis And Industry Forecast (2017-2022)

Published by Meticulous Market Research Pvt. Ltd. Product code 581403
Published Content info 151 Pages
Delivery time: 1-2 business days
Price
Back to Top
Diabetes Care Devices Market - Global Opportunity Analysis And Industry Forecast (2017-2022)
Published: November 21, 2017 Content info: 151 Pages
Description

Diabetes Care Devices Market by Monitoring Devices (Test Strips, Self-Monitoring Devices, CGM Devices, Lancets, Hemoglobin A1c Testing Kits) and Insulin Delivery Devices (Insulin Pens, Insulin Syringes, Insulin Pumps, Insulin Jet Injectors) - Global Opportunity Analysis and Industry Forecast To 2022.

Advances in diabetes treatment and technology over the past several decades have fundamentally transformed the lives of millions of people with diabetes mellitus globally.

Diabetes is a chronic disease characterized by the inability of the pancreas to produce enough insulin, or when the body cannot effectively use the insulin it produces. Uncontrolled diabetes results in the increasing blood glucose (hyperglycaemia); in line with this, diabetes care products have evolved for the treatment of both type 1 diabetes and type 2 diabetes. Diabetes care management has plethora of opportunities for the diagnosis, monitoring, and treatment of the disease.

The global diabetes care devices market is expected to grow at a CAGR of 5.3% from 2017 to 2022 to reach $26,710.3 million by 2022. On the basis of an extensive outlook on the global diabetes care devices market, the report carries out an impact analysis of the key industry drivers and restraints listed in the market insights segment. Increasing prevalence of diabetes, technological advancements, rise in obese population, sedentary lifestyle & improper diet, and increasing need for faster and safer diagnosis and treatment of diabetes are the key market drivers covered in the report which will support the industry growth in the forecast period. However, high cost associated with diagnosis and treatment, reimbursement issues for new technologies, and lack of awareness about the timely care of the disease for its better management are the major pain points, restraining the adoption of the diabetes care devices.

The global diabetes care devices market studied in this report is mainly segmented by product type and geography. Based on the product type, the global diabetes care devices market is mainly segmented into monitoring devices and insulin delivery devices. The monitoring devices segment holds the major share of the global diabetes care devices market, owing to the increased adoption of test strips and self-monitoring blood glucose devices across the globe. With the increasing trend of self-management and the rising awareness towards the disease in the developing countries, these devices can be utilized to aid in adjustment of therapeutic regimen in response to blood glucose values and to help patient adjust their dietary intake, physical activity, and insulin doses to improve glycaemic control on a regular basis.

An exhaustive analysis of the geographical scenario of the industry for the five major geographies: North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa is included in the geographical analysis section. These regions are further analyzed at a country level with the detailed qualitative and quantitative analysis. The geographical analysis provides detailed insights on the key trends of the industry in the listed regions & countries, identifying the demographic & economic impact, government & private investments, and regulatory scenario. The report identifies North America to be the largest market, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa. The geographical analysis section also comments on the key market players shaping the growth of the industry in the respective countries.

image1

The report also includes the competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 3 years (2014-2017). The study has also incorporated the market share analysis of leading players and detailed profiles of top 10 market players including detailed financial performance, product offerings, and strategic growth initiatives of each player.

The key players operating in the global diabetes care devices market are Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland), Abbott (U.S.), Ascensia Diabetes Care Holdings AG (Switzerland), F. Hoffmann-La Roche AG. (Switzerland), Johnson & Johnson (U.S.), Medtronic Plc. (Ireland), Becton, Dickinson and Company (U.S.), Terumo Corporation (Japan), and Sanofi AS (France).

Scope of the Report

Market by Type

  • Diabetes monitoring devices
    • Test strips
    • Self-monitoring devices
    • Continuous blood glucose monitoring devices
    • Lancets
    • Haemoglobin A1c testing kits
  • Insulin delivery devices
    • Insulin Pens
    • Insulin Syringes
    • Insulin Pumps
    • Insulin Jet Injectors

Market by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • Rest of World
    • Latin America
    • Middle East and Africa
Table of Contents
Product Code: MRMD-10436

Table of Contents

1. Introduction

  • 1.1. Market Ecosystem
  • 1.2. Currency and Limitations
    • 1.2.1. Currency
    • 1.2.2. Limitations
  • 1.3. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
    • 2.1.1. Secondary Research
    • 2.1.2. Primary Research
    • 2.1.3. Market Size Estimation

3. Executive Summary

4. Market Insights

  • 4.1. Introduction
  • 4.2. Drivers
    • 4.2.1. Increasing Incidence & Prevalence of Diabetes
    • 4.2.2. Technological Advancements
    • 4.2.3. Rise in Obesity
    • 4.2.4. Increasing Sedentary Lifestyle and Improper Diet
    • 4.2.5. Other Drivers
  • 4.3. Restraints
    • 4.3.1. High Cost Associated with Diagnosis and Treatment
    • 4.3.2. Reimbursement Issues
    • 4.3.3. Other Restraints
    • 4.3.3. Lack of Awareness
  • 4.4. Opportunities
    • 4.4.1. Development of Advanced Insulin Delivery Technologies
    • 4.4.2. Other Opportunities
  • 4.5. Challenges
    • 4.5.1. Stringent Regulations and Registration Process
    • 4.5.2. Other Challenges
  • 4.6. Regulatory Analysis
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia-Pacific
  • 4.7. Market Share Analysis, by Key Players

5. Diabetes Care Devices Market, By Type

  • 5.1. Introduction
  • 5.2. Diabetes Monitoring Devices
    • 5.2.1. Continuous Blood Glucose Monitoring Devices
    • 5.2.2. Test Strips
    • 5.2.3. Lancets
    • 5.2.4. Self-Monitoring Blood Glucose Devices
    • 5.2.5. Hemoglobin A1c Testing Kits
  • 5.3. Insulin Delivery Devices
    • 5.3.1. Insulin Syringes
    • 5.3.2. Insulin Pens
    • 5.3.3. Insulin Pumps
    • 5.3.4. Insulin Jet Injectors

6. Diabetes Care Devices Market, By Geography

  • 6.1. Introduction
  • 6.2. North America
    • 6.2.1. U.S.
    • 6.2.2. Canada
  • 6.3. Europe
    • 6.3.1. Germany
    • 6.3.2. France
    • 6.3.3. Italy
    • 6.3.4. Spain
    • 6.3.5. U.K.
    • 6.3.6. RoE
  • 6.4. Asia-Pacific
    • 6.4.1. Japan
    • 6.4.2. China
    • 6.4.3. India
    • 6.4.4. RoAPAC
  • 6.5. RoW
    • 6.5.1. Latin America
    • 6.5.2. Middle East & Africa

7. Competetive Landscape

  • 7.1. Collaborations, Partnerships & Agreements
  • 7.2. New Product Launches
  • 7.3. Approvals
  • 7.4. Expansions
  • 7.5. Acquisitions
  • 7.6. Others

8. Company Profiles (Overview, Financials, Product Portfolio, Recent Developments)

  • 8.1. Novo Nordisk A/S
    • 8.1.1. Overview
    • 8.1.2. Financials
    • 8.1.3. Product Portfolio
    • 8.1.4. Recent Developments
  • 8.2. Ypsomed AG
  • 8.3. Abbott Laboratories
  • 8.4. Ascensia Diabetes Care Holdings AG
  • 8.5. F.Hoffmann-La Roche AG
  • 8.6. Johnson & Johnson
  • 8.7. Medtronic Plc
  • 8.8. Becton, Dickinson And Company
  • 8.9. Terumo Corporation
  • 8.10. Sanofi AS

9. Appendix

  • 9.1. Questionnaire
  • 9.2. Available Customization

List of Tables

  • Table 1 Diabetes Care Devices Market Drivers: Impact Analysis (2017-2022)
  • Table 2 Technological Advancements by The Leading Companies, 2014-2017
  • Table 3 Diabetes Care Devices Market Restraints: Impact Analysis (2017-2022)
  • Table 4 Proportion and Number of People (20-79 Years) Living with Diabetes Who Are Undiagnosed, 2015
  • Table 5 Global Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 6 Global Diabetes Care Devices Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 7 Global Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 8 Global Diabetes Monitoring Devices Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 9 Global Continuous Glucose Monitoring Devices Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 10 Reimbursement Limits for Test Strips
  • Table 11 Global Test Strips Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 12 Global Lancets Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 13 Global Self-Monitoring Blood Glucose Devices Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 14 Global Hemoglobin A1c Testing Kits Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 15 Global Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 16 Global Insulin Delivery Devices Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 17 Global Insulin Syringes Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 18 Global Insulin Pens Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 19 Global Insulin Pumps Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 20 Global Insulin Jet Injectors Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 21 Global Diabetes Care Devices Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 22 North America: Diabetes Care Devices Market Size, by Country, 2015-2022 (USD Million)
  • Table 23 North America: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 24 North America: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 25 North America: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 26 U.S.: Diabetes Indicators, 2016
  • Table 27 Estimated Number and Percentage of Diagnosed and Undiagnosed Diabetes Among Adults, U.S., 2015
  • Table 28 U.S.: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 29 U.S.: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 30 U.S.: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 31 Diabetes Statistics in Canada, 2016-2026
  • Table 32 Canada: Diabetes Indicators, 2016
  • Table 33 Canada: Diabetes Care Devices Market size, by Type, 2015-2022 (USD Million)
  • Table 34 Canada: Diabetes Monitoring Devices Market size, by Type, 2015-2022 (USD Million)
  • Table 35 Canada: Insulin Delivery Devices Market Size, By Type, 2015-2022 (USD Million)
  • Table 36 Europe: Diabetes Care Devices Market Size, by Country, 2015-2022 (USD Million)
  • Table 37 Europe: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 38 Europe: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 39 Europe: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 40 Germany: Diabetes Indiactors, 2016
  • Table 41 Germany: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 42 Germany: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 43 Germany: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 44 France: Diabetes Indicators, 2016
  • Table 45 France: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 46 France: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 47 France: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 48 Italy: Diabetes Indicators, 2016
  • Table 49 Italy: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 50 Italy: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 51 Italy: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 52 Spain: Diabetes Indicators, 2016
  • Table 53 Spain: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 54 Spain: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 55 Spain: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 56 U.K.: Diabetes Indicators, 2016
  • Table 57 U.K: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 58 U.K: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 59 U.K.: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 60 RoE: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 61 RoE: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 62 RoE: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 63 APAC: Diabetes Care Devices Market Size, by Country, 2015-2022 (USD Million)
  • Table 64 APAC: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 65 APAC: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 66 APAC: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 67 Japan: Diabetes Indicators, 2016
  • Table 68 Japan: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 69 Japan: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 70 Japan: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 71 China: Diabetes Indicators, 2016
  • Table 72 China: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 73 China: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 74 China: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 75 India: Diabetes Indicators, 2016
  • Table 76 India: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 77 India: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 78 India: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 79 RoAPAC: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 80 RoAPAC: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 81 RoAPAC: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 82 RoW: Diabetes Care Devices Market Size, by Country, 2015-2022 (USD Million)
  • Table 83 RoW: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 84 RoW: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 85 RoW: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 86 Latin America: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 87 Latin America: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 88 Latin America: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 89 Middle East & Africa: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 90 Middle East & Africa: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 91 Middle East & Africa: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 92 Number of Developments by The Leading Players, 2015-2017

List of Figures

  • Figure 1 Research Process
  • Figure 2 Key Executives Interviewed
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Opportunities
  • Figure 5 Global Diabetes Care Devices Market Size, by Type, 2017-2022 (USD Million)
  • Figure 6 Test Strips Dominates the Self-Monitoring Devices Market
  • Figure 7 Diabetes Care Devices Market Overview- 2017-2022
  • Figure 8 Key Growth Strategies Adopted by Leading Players -2015-2017
  • Figure 9 Market Dynamics
  • Figure 10 Rising Overweight (Including Obesity) Rates in Adults Aged 15-74 Years
  • Figure 11 Diabetes Care Devices Market Share, by Key Players, 2016
  • Figure 12 Global Diabetes Care Devices Market Size, by Type, 2017-2022
  • Figure 13 Global Diabetes Care Devices Market Size, by Country/ Region, 2017-2022 (USD Million)
  • Figure 14 Mortality Due to Diabetes in North America, by Age Group, 2015
  • Figure 15 A Snapshot of Diabetes in The U.S., 2017
  • Figure 16 Cost of Diabetes in Canada, 2000-2020
  • Figure 17 Comparative Prevalence of Diabetes in Adults in EU-Countries, 2016
  • Figure 18 Percentage of Total Death in Germany, By Type of Disease, 2016
  • Figure 19 Number of Patients with Type-2 Diabetes in Germany, 2006-2014
  • Figure 20 Distribution of Total Expenditure Per Healthcare Item, 2013
  • Figure 21 Projected Rate of Obesity, 2000-2030
  • Figure 22 Facts & Figures of Diabetes in Italy, 2016
  • Figure 23 Diabetes Prevalence in EU Member Countries, 2017
  • Figure 24 Prevalence of Diabetes in Japan, 2000-2030
  • Figure 25 Healthcare Costs for Diabetes by Latin American Countries, 2010-2025 (USD Million)
  • Figure 26 Key Growth Strategies Adopted by Leading Players -2015-2017
  • Figure 27 Partnerships, Agreements & Collaborations by Profiled Companies, 2015-2017
  • Figure 28 New Product Launches by the Leading Companies, 2015-2017
  • Figure 29 Approvals Received by the Leading Companies, 2015-2017
  • Figure 30 Expansions by the Leading Companies, 2015-2017
  • Figure 31 Novo Nordisk A/S: Financial Overview- 2014-2016
  • Figure 32 Ypsomed Ag: Financial Overview- 2015-2017
  • Figure 33 Abbott Labratories: Financial Overview- 2014-2016
  • Figure 34 Panasonic Corporation (A Parent Company of Ascensia Diabetes Care Holdings AG): Financial Overview- 2015-2017
  • Figure 35 F. Hoffmann-La Roche AG.: Financial Overview- 2014-2016
  • Figure 36 Johnson & Johnson: Financial Overview- 2014-2016
  • Figure 37 Medtronic Plc: Financial Overview- 2015-2017
  • Figure 38 Becton, Dickinson And Company: Financial Overview- 2014-2016
  • Figure 39 Terumo Corporation: Financial Overview- 2014-2016
  • Figure 40 Sanofi AS: Financial Overview- 2014-2016
Back to Top